Cellebrite DI (CLBT) Company Report

Cellebrite's CEO, Tom Hogan, transitioned to permanent CEO after serving as interim, citing the company's mission and significant economic opportunity as key motivators.
The company announced the closing of its acquisition of Corellium, which virtualizes ARM-based devices, expanding Cellebrite's platform and growth opportunities, particularly in DevSecOps and pen testing.
Cellebrite anticipates a resurgence of growth in the U.S. federal sector in calendar 2026, driven by leadership stability, earmarked funds, and expected FedRAMP authorization for cloud products in Q1 2026.
The company is leveraging Artificial Intelligence (AI) to enhance its core products and develop agentic applications for digital investigations, aiming to improve efficiency and solve complex crimes while maintaining human oversight for legal traceability.
Cellebrite currently operates at a 30% free cash flow margin, with expectations for this to continue climbing, and identifies drivers for future ARR growth including new logos, platform selling, and adoption of key products like Inseyets, Guardian, and Pathfinder.

3 days ago

Transcript

Cellebrite discusses Corellium acquisition, CEO transition, and 2026 growth outlook

CLBT

M&A

CEO Change

Guidance Update

Cellebrite announced the closing of its acquisition of Corellium, which virtualizes Arm-based devices, expanding its platform and total addressable market (TAM).
CEO Tom Hogan confirmed his transition to full-time CEO after serving as interim, citing the company's mission and economic opportunity.
The company anticipates a resurgence of growth in the U.S. Federal sector in calendar 2026, driven by leadership stability, earmarked funds, and expected Level 4 FedRAMP certification in Q1 2026.
Cellebrite maintains a strong financial position, running at a 30% free cash flow margin and identifying multiple drivers for future ARR growth, including new logos, platform sales, and product adoption.
The company is leveraging AI internally for productivity and externally to enhance digital investigations, helping process vast amounts of evidence and accelerate case resolution.

3 days ago

Transcript

Cellebrite Discusses Corellium Acquisition, Growth Strategy, and Financial Outlook at UBS Conference

CLBT

M&A

New Projects/Investments

Guidance Update

Cellebrite announced the closing of its acquisition of Corellium this week, which will expand its platform by providing unique virtualization and emulation capabilities for ARM-based devices, targeting the DevSecOps, pen testing, and public sector markets.
The company expects a resurgence of growth in the U.S. federal sector in 2026, driven by leadership stability, significant funding earmarked for initiatives like fentanyl and border control, and anticipated FedRAMP Level 4 certification for cloud products in Q1 2026.
Cellebrite is focused on extending its leadership from digital forensics into the broader investigative world, aiming to leverage forensic data to drive case closure, which represents a significantly larger market opportunity.
Financially, Cellebrite is operating with a 30% free cash flow margin and aims for a Rule of 50 performance, with a plan to achieve 20%+ top-line growth next year.

3 days ago

Transcript

Cellebrite Completes Corellium Acquisition

CLBT

M&A

New Projects/Investments

Guidance Update

Cellebrite DI Ltd. completed its acquisition of Corellium, Inc. on December 1, 2025.
The acquisition had an enterprise value of $170 million, comprising $150 million in cash at closing and $20 million converted to equity.
Corellium securityholders are eligible for up to an additional $30 million in cash based on the achievement of certain performance milestones over the next two years.
The acquisition is intended to expand Cellebrite's AI-powered Digital Investigative and Intelligence solutions, with Corellium's co-founder and CTO, Chris Wade, joining Cellebrite's leadership team as CTO.
The impact of Corellium's revenue and costs for one month in Q4 2025 is not expected to be material to Cellebrite's previously issued Q4 and full-year 2025 outlook.

3 days ago

6-K

Cellebrite Reports Strong Q3 2025 Results and Announces Corellium Acquisition

CLBT

Earnings

Guidance Update

M&A

Cellebrite reported strong Q3 2025 results, with total revenue increasing 18% to $126 million and subscription revenue growing 21% to $113 million compared to Q3 2024. Annual Recurring Revenue (ARR) reached $440 million as of September 30, 2025, a 19% increase year-over-year.
Adjusted EBITDA for Q3 2025 was $38 million, representing a 30% margin. The company demonstrated strong liquidity with $595.3 million in cash and investments as of Q3 2025 , and Free Cash Flow grew 37% to $140.3 million for the trailing twelve months ending September 30, 2025, with a 30.8% margin.
Cellebrite announced the acquisition of Corellium, aiming for TAM expansion and innovation, broadening offerings for Defense and Intelligence, and extending reach into DevSecOps. The company provided a positive outlook for FY 2025, expecting ARR between $460 million and $475 million and total revenue between $470 million and $475 million.

Nov 12, 2025, 10:00 PM

Presentation

Celebrite Reports Strong Q3 2025 Results, Raises Full-Year Adjusted EBITDA Outlook, and Advances Strategic Initiatives

CLBT

Earnings

Guidance Update

M&A

Celebrite reported strong Q3 2025 financial results, with ARR growing 19% to $440 million and revenue increasing 18% to $126 million. Adjusted EBITDA rose 20% to $37.7 million, expanding margins by 60 basis points.
The company raised its full-year 2025 adjusted EBITDA outlook to $127 million (26% to 27% margin) and increased the midpoint of its revenue outlook to a range of $470 million to $475 million.
Strategic progress includes 47% conversion of the digital forensics license base to Insights and SaaS and cloud ARR growing over 100% for the fifth consecutive quarter. The U.S. Federal segment also returned to growth in Q3.
Celebrite anticipates closing the $150 million Keryllium acquisition in Q4 2025 and launching the AI-powered Guardian Investigate solution in early 2026, both expected to drive future growth.

Nov 12, 2025, 10:00 PM

Transcript

Cellebrite Announces Third-Quarter 2025 Results

CLBT

Earnings

Guidance Update

Product Launch

Cellebrite reported third-quarter 2025 revenue of $126.0 million, an 18% year-over-year increase, and Annual Recurring Revenue (ARR) of $439.8 million, up 19% year-over-year.
For Q3 2025, the company achieved GAAP net income of $20.2 million and adjusted EBITDA of $37.7 million.
The company provided full-year 2025 revenue expectations of $470 million to $475 million, ARR expectations of $460 million to $475 million, and Adjusted EBITDA expectations of $124 million to $127 million.
Key business developments include the Autumn 2025 Release on October 15, 2025, evolving its Digital Investigation Platform with new integrations and AI-powered analysis, and the appointment of Holly Windham as General Counsel and Chief Compliance Officer on October 30, 2025.

Nov 12, 2025, 9:15 PM

6-K

Cellebrite Announces Third-Quarter 2025 Results and Full-Year Outlook

CLBT

Earnings

Guidance Update

Product Launch

Cellebrite reported strong third-quarter 2025 financial results, with revenue of $126.0 million, an 18% increase year-over-year, and Annual Recurring Revenue (ARR) growing 19% to $439.8 million. The company achieved GAAP net income of $20.2 million and non-GAAP net income of $36.9 million, alongside Adjusted EBITDA of $37.7 million.
For the full-year 2025, Cellebrite expects ARR between $460 million and $475 million and revenue between $470 million and $475 million. Adjusted EBITDA is projected to be between $124 million and $127 million.
The company announced its Autumn 2025 Release on October 15, 2025, which includes advancements to its Digital Investigation Platform, such as the expanded Guardian suite with the upcoming SaaS-based Guardian Investigate solution scheduled for general availability in early 2026.
Holly Windham was appointed as General Counsel and Chief Compliance Officer on October 30, 2025.

Nov 12, 2025, 9:01 PM

Press Release

ValueAct Capital Files Large Shareholder Report in Sun Corp, Citing Cellebrite Investment

CLBT

New Projects/Investments

ValueAct Capital has filed a Large Shareholding Report in Sun Corporation (TSE: 6736), disclosing an approximate 7.8% position of the shares outstanding.
ValueAct Capital expressed respect for Sun's businesses and its historical sponsorship of Cellebrite (NASDAQ:CLBT), the world's leading digital investigations platform.
ValueAct believes Sun is on a path to maximize the value of its Cellebrite investment, which is expected to benefit all stakeholders of both companies, and looks forward to further engagement with their management.

Oct 9, 2025, 11:00 AM

Press Release

Cellebrite Reports Strong 2024 Financials, Appoints New CEO, and Announces Strategic Acquisitions

CLBT

Earnings

CEO Change

M&A

Cellebrite reported strong financial results for 2024, with annual recurring revenue (ARR) growing 25% to $395.9 million and total revenue increasing 23% to $401.2 million. Adjusted EBITDA reached $99.4 million, representing a 25% margin. The company also achieved a Rule of 50 performance and increased its cash position by 46% to $483.8 million in 2024.
For the first six months of 2025, total revenue grew 19% to $220.9 million, and adjusted EBITDA increased 32% to $51.6 million compared to the same period in 2024. ARR for the 12-months ended June 30, 2025, increased 21% to $418.9 million, and the cash position grew 15% to $557.8 million as of the same date.
Thomas E. Hogan was appointed Chief Executive Officer on August 12, 2025, following his role as Interim CEO since January 1, 2025. His compensation package, including an annual retainer of $520,000 and an annual bonus target of $500,000, along with equity grants, is subject to shareholder approval at the upcoming Annual General Meeting.
The company announced the agreement to acquire Corellium in June 2025 to expand its total addressable market and accelerate innovation. Additionally, Cellebrite established Cellebrite Federal Solutions and acquired CyTech in July 2024 to enhance its engagement with U.S. federal customers.
Dana Gerner will retire as CFO in mid-August 2025, and David Barter has been appointed as the new CFO. The Annual General Meeting of Shareholders is scheduled for September 19, 2025, with a record date of August 12, 2025, to vote on proposals including director re-elections, CEO compensation, and auditor re-appointment.

Aug 15, 2025, 12:00 AM

6-K

Earnings Transcripts

Quarterly earnings call transcripts for Cellebrite DI.

Ask Fintool AI Agent

Get instant answers from SEC filings, earnings calls & more

What are Cellebrite DI's strategic priorities?How is Cellebrite DI positioned vs competitors?How did Cellebrite DI do last quarter?

Let Fintool AI Agent track Cellebrite DI's earnings for you

Get instant analysis when filings drop